Skip to main content

ImmunityBio, Inc.

IBRX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001326110

In the last 90 days, ImmunityBio, Inc. insiders filed 0 open-market purchases and 3 sales; 405 institutions reported holding it in 13F filings for Q2 2026, worth $1.76B in total; no superinvestor holds it.

13F holders, Q3 2021

Institutional positions in ImmunityBio, Inc. as of Sep 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
121
+6 vs. Q2 2021
Shares held
31.9M
+4.47M (+16.3%) vs. Q2 2021
Total value
$310.9M
−$74.6M (−19.3%) vs. Q2 2021
New holders
20
50 more added
Sold out
14
26 more reduced

3 institutions that held it in Q2 2021 haven't filed for Q3 2021 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q2 2021: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting IBRX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ3 2021: 121 institutions
Q1 2021: 116 institutionsQ2 2021: 118 institutionsQ3 2021: 121 institutionsQ4 2021: 141 institutionsQ1 2022: 149 institutionsQ2 2022: 132 institutionsQ3 2022: 126 institutionsQ4 2022: 140 institutionsQ1 2023: 147 institutionsQ2 2023: 118 institutionsQ3 2023: 132 institutionsQ4 2023: 148 institutionsQ1 2024: 166 institutionsQ2 2024: 194 institutionsQ3 2024: 182 institutionsQ4 2024: 202 institutionsQ1 2025: 211 institutionsQ2 2025: 242 institutionsQ3 2025: 264 institutionsQ4 2025: 278 institutionsQ1 2026: 386 institutionsQ2 2026: 405 institutions
Value heldQ3 2021: $310.9M
Q1 2021: $378.9MQ2 2021: $390.1MQ3 2021: $310.9MQ4 2021: $209.7MQ1 2022: $199.8MQ2 2022: $123.1MQ3 2022: $196.3MQ4 2022: $256.0MQ1 2023: $84.1MQ2 2023: $108.7MQ3 2023: $84.1MQ4 2023: $288.9MQ1 2024: $356.9MQ2 2024: $391.1MQ3 2024: $255.6MQ4 2024: $211.8MQ1 2025: $239.4MQ2 2025: $327.9MQ3 2025: $352.1MQ4 2025: $338.3MQ1 2026: $1.36BQ2 2026: $1.76B
Institutions holding IBRX and their total value by quarter
QuarterHoldersValue
Q2 2026405$1.76B
Q1 2026386$1.36B
Q4 2025278$338.3M
Q3 2025264$352.1M
Q2 2025242$327.9M
Q1 2025211$239.4M
Q4 2024202$211.8M
Q3 2024182$255.6M
Q2 2024194$391.1M
Q1 2024166$356.9M
Q4 2023148$288.9M
Q3 2023132$84.1M
Q2 2023118$108.7M
Q1 2023147$84.1M
Q4 2022140$256.0M
Q3 2022126$196.3M
Q2 2022132$123.1M
Q1 2022149$199.8M
Q4 2021141$209.7M
Q3 2021121$310.9M
Q2 2021118$390.1M
Q1 2021116$378.9M

Institutions, Q3 2021

Shares, value and share of portfolio for each institution holding ImmunityBio, Inc.; share changes are against Q2 2021.

Institutions holding IBRX in Q3 2021
InstitutionSharesValue% of portfolioChange in sharesAction
ClariVest Asset Management LLC206,332$2.01M0.06%−10,093−4.7%Reduced
Renaissance Technologies LLC207,917$2.02M0.00%+207,917New
Goldman Sachs Group Inc225,747$2.20M0.00%+29,340+14.9%Added
Nuveen Asset Management, LLC266,436$2.60M0.00%−311,464−53.9%Reduced
UBS Group AG278,699$2.71M0.00%+251,520+925.4%Added
Pictet Asset Management SA311,234$3.03M0.00%+311,234New
HarbourVest Partners LLC335,709$3.27M0.31%00.0%Unchanged
Bank of New York Mellon Corp351,580$3.42M0.00%+41,531+13.4%Added
D. E. Shaw & Co., Inc.377,470$3.68M0.00%+293,098+347.4%Added
Credit Suisse AG391,661$3.81M0.00%+213,636+120.0%Added
Rafferty Asset Management, LLC451,039$4.39M0.03%+33,261+8.0%Added
Charles Schwab Investment Management Inc458,205$4.46M0.00%−33,654−6.8%Reduced
Morgan Stanley497,724$4.85M0.00%+9,434+1.9%Added
Allen Holding Inc687,571$6.70M0.99%00.0%Unchanged
Susquehanna International Group, LLP885,444$8.62M0.01%+120,263+15.7%Added
JPMorgan Chase & Co1,195,309$11.6M0.00%+572,285+91.9%Added
Northern Trust Corp1,258,399$12.3M0.00%−90,296−6.7%Reduced
Geode Capital Management, LLC1,516,256$14.8M0.00%+46,560+3.2%Added
State Street Corp5,317,780$51.8M0.00%+1,124,160+26.8%Added
BlackRock Inc.5,551,568$54.1M0.00%+278,411+5.3%Added
Vanguard Group Inc7,031,258$68.5M0.00%+1,471,235+26.5%Added
First Trust Advisors LP0$00.00%−250,096−100.0%Sold out
Engineers Gate Manager LP0$00.00%−87,745−100.0%Sold out
Two Sigma Investments, LP0$00.00%−85,579−100.0%Sold out
Twinbeech Capital LP0$00.00%−83,765−100.0%Sold out
Arrowstreet Capital, Limited Partnership0$00.00%−65,700−100.0%Sold out
Squarepoint Ops LLC0$00.00%−62,550−100.0%Sold out
Cambridge Investment Research Advisors, Inc.0$00.00%−28,568−100.0%Sold out
Illinois Municipal Retirement Fund0$00.00%−15,973−100.0%Sold out
Jackson, Grant Investment Advisers, Inc.0$00.00%−5,000−100.0%Sold out
Dark Forest Capital Management LP0$00.00%−3,692−100.0%Sold out
Point72 Hong Kong Ltd0$00.00%−310−100.0%Sold out
Sugarloaf Wealth Management, LLC0$00.00%−200−100.0%Sold out
Tradition Wealth Management, LLC0$00.00%−200−100.0%Sold out
FMR LLC0$00.00%−100−100.0%Sold out
Pictet Asset Management Ltd––––Not filed
QS Investors, LLC––––Not filed
CWM, LLC––––Not filed